Sign In
Get Clay Free →

Suggestions

    Robert Brown

    Senior Vice President Clinical Development at Nurix Therapeutics

    Robert Brown is a drug development leader specializing in ubiquitin E3 ligase-mediated protein modulation for treating hematologic and non-hematologic malignancies. He has a strong background in targeted degradation, immunomodulatory small molecules, and drug-enhanced cell therapy. Robert holds an S.B. in Chemistry from the Massachusetts Institute of Technology and an M.D. in Medicine from Joan & Sanford I. Weill Medical College of Cornell University. He completed a Fellowship in Pediatric Hematology-Oncology at Yale University School of Medicine. Throughout his career, Robert has held key positions in several prestigious organizations, including Nurix Therapeutics, Allogene Therapeutics, Aduro Biotech, Iovance Biotherapeutics, Inc., and Insys Therapeutics, Inc. He has also served in various roles at UCLA, Childrens Hospital Los Angeles, University of Southern California, and Yale University School of Medicine.

    R
    Add to my network

    Location

    San Francisco, California, United States